2024/10/18 08:01:50 | |
---|---|
Price | |
55.47 EUR | |
Difference | 0.00% (0.00) |
ISIN | US1488061029 |
Symbol | CTLT |
Exchange | Munich |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 10,103 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 55.47 EUR |
High | 55.47 EUR |
Low | 55.47 EUR |
Close (prev. day) | 55.47 EUR |
VWAP | 53.50 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings |
2024/10/18 08:01:50 | |
---|---|
Price | |
55.47 EUR | |
Difference | 0.00% (0.00) |
ISIN | US1488061029 |
Symbol | CTLT |
Exchange | Munich |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 10,103 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 55.47 EUR |
High | 55.47 EUR |
Low | 55.47 EUR |
Close (prev. day) | 55.47 EUR |
VWAP | 53.50 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | +5.14% | +27.37% | -50.03% |
Perf (abs.) | +2.71 | +11.92 | -55.53 |
Beta | 0.14 | 0.55 | 1.11 |
Volatility | 7.24 | 28.85 | 47.85 |
Ø price 5 days | Ø volume 5 days (pcs.) | 55.45 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 54.54 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 53.59 EUR (0) |
Ø price 250 days | Ø volume 250 days (pcs.) | 49.16 EUR (1) |
YTD High | date | 56.00 EUR (2024/02/06) |
YTD Low | date | 39.35 EUR (2024/01/04) |
52 Weeks High | date | 56.00 EUR (2024/02/06) |
52 Weeks Low | date | 31.15 EUR (2023/11/03) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Berlin | 2024/10/18 | 08:02 | 54.94 EUR | 0.00 | 2 |
Frankfurt | 2024/10/18 | 08:01 | 54.92 EUR | 0.00 | 2 |
Munich | 2024/10/18 | 08:01 | 55.47 EUR | 0.00 | 1 |
NYSE | 2024/10/18 | 22:00 | 60.29 USD | 54.66 | 9,070 |
Stuttgart | 2024/10/18 | 21:31 | 55.40 EUR | 0.00 | 8 |
Tradegate | 2024/10/18 | 22:26 | 55.47 EUR | 0.01 | 3 |
CATALENT INC. |
- - |
14 Schoolhouse Road - 08873 Somerset |
Telefon: +1-732-537-6200 |
Fax: + |
E-mail: info@catalent.com |
Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It operates through the following segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment offers formulation, development, and manufacturing services for soft capsules or softgels, as well as large-scale production of oral solid dose forms for pharmaceutical and consumer health markets and supporting ancillary services. The Biologics segment develops and produces biologic cell-line, cell therapy, and viral vector gene therapy, formulation for parenteral dose forms, which include prefilled syringes, vials, and cartridges, and analytical development and testing services for large molecules. The Oral and Specialty Delivery segment is composed of advanced formulation of a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is involved in packaging, storage, distribution, and inventory management of drugs and biologics in clinical trials. The company was founded in 1933 and is headquartered in Somerset, NJ. |
John Greisch | Chairman of Board of Directors |
Donald Morel | Member of Board of Directors |
Frank D'Amelio | Member of Board of Directors |
Gregory Lucier | Member of Board of Directors |
J. Carroll | Member of Board of Directors |
Jack Stahl | Member of Board of Directors |
Michael Barber | Member of Board of Directors |
Michelle Ryan | Member of Board of Directors |
Rolf Classon | Member of Board of Directors |
Stephanie Okey | Member of Board of Directors |
Steven Barg | Member of Board of Directors |
Alessandro Maselli | Chairman of Managing Board |
Charles Lickfold | Member of Executive Committee |
Joseph A. Ferraro | Member of Executive Committee |
Lisa Evoli | Member of Executive Committee |
Matti Masanovich | Member of Executive Committee |
Michael Hatzfeld | Member of Executive Committee |
Ricky Hopson | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer